OPK
Opko Health Inc
NASDAQ: OPK · HEALTHCARE · DIAGNOSTICS & RESEARCH
$1.13
+1.35% today
Updated 2026-04-30
Market cap
$838.15M
P/E ratio
—
P/S ratio
1.38x
EPS (TTM)
$-0.27
Dividend yield
—
52W range
$1 – $2
Volume
2.5M
Opko Health Inc (OPK) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-37.20%
Operating margin
-29.00%
ROE
-17.10%
ROA
-6.62%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | — | $-648000.00 | — | — | — |
| 2007 | $847000.00 | $-268.40M | 4.60% | -31,624.44% | -31,688.90% |
| 2008 | $9.44M | $-39.83M | 9.33% | -393.70% | -421.97% |
| 2009 | $13.15M | $-30.11M | 27.23% | -173.57% | -229.05% |
| 2010 | $28.49M | $-18.93M | 52.64% | -39.08% | -66.42% |
| 2011 | $27.98M | $-1.28M | 38.37% | -82.88% | -4.59% |
| 2012 | $47.04M | $-29.05M | 40.74% | -79.22% | -61.75% |
| 2013 | $96.53M | $-114.41M | 49.38% | -82.49% | -118.52% |
| 2014 | $91.10M | $-171.70M | -160.04% | -160.04% | -188.47% |
| 2015 | $491.70M | $-30.00M | -20.03% | -20.03% | -6.10% |
| 2016 | $1.22B | $-48.36M | 49.95% | -6.00% | -3.96% |
| 2017 | $966.01M | $-305.25M | 35.80% | -28.62% | -31.60% |
| 2018 | $990.30M | $-153.04M | 38.95% | -17.29% | -15.45% |
| 2019 | $901.93M | $-314.93M | 36.53% | -30.38% | -34.92% |
| 2020 | $1.44B | $30.59M | 37.69% | 4.02% | 2.13% |
| 2021 | $1.77B | $-30.14M | 32.77% | 1.06% | -1.70% |
| 2022 | $1.00B | $-328.40M | 28.70% | -22.53% | -32.70% |
| 2023 | $863.50M | $-188.86M | 36.84% | -18.18% | -21.87% |
| 2024 | $713.14M | $-53.22M | 43.61% | -21.32% | -7.46% |
| 2025 | $606.88M | $-225.73M | 21.10% | -36.08% | -37.20% |